Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibaud Valentin

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer Medicine|December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma groupMehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETOJean-Yves Blay, Nicolas Penel, Maud Toulmonde, et al.
International Journal of Cancer|July 24, 2025
Metastatic chondrosarcoma, patterns of care, and outcomes of patients in a real-life national setting over a decadeColine Ducrot, Derek Dinart, Mathilde Reich, et al.
Cancer Medicine|June 3, 2026
Metastatic Ewing Sarcoma, Patterns of Care and Outcomes of Patients in a Real-Life National Setting Over a DecadeColine Ducrot, Derek Dinart, Maeva Bonneau, et al.
BMC Cancer|February 14, 2020
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)Anna Patrikidou, Loic Chaigneau, Nicolas Isambert, et al.
International Journal of Cancer|September 29, 2025
Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life national setting over a decadeMathilde Reich, Derek Dinart, Hélène Bellio, et al.
Cancers|January 21, 2023
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of LeiomyosarcomasElodie Darbo, Gaëlle Pérot, Lucie Darmusey, et al.
The Lancet. Oncology|July 10, 2023
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trialJean-Yves Blay, Sylvie Chevret, Axel Le Cesne, et al.
Cancer|March 12, 2024
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intentJustine Gantzer, Maud Toulmonde, François Severac, et al.
British Journal of Cancer|November 17, 2025
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trialValérie Laurence, Nina Jehanno, Sylvain Dureau, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Medicine|December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma groupMehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETOJean-Yves Blay, Nicolas Penel, Maud Toulmonde, et al.
International Journal of Cancer|July 24, 2025
Metastatic chondrosarcoma, patterns of care, and outcomes of patients in a real-life national setting over a decadeColine Ducrot, Derek Dinart, Mathilde Reich, et al.
Cancer Medicine|June 3, 2026
Metastatic Ewing Sarcoma, Patterns of Care and Outcomes of Patients in a Real-Life National Setting Over a DecadeColine Ducrot, Derek Dinart, Maeva Bonneau, et al.
BMC Cancer|February 14, 2020
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA)Anna Patrikidou, Loic Chaigneau, Nicolas Isambert, et al.
International Journal of Cancer|September 29, 2025
Metastatic osteosarcoma, patterns of care and outcomes of patients in a real-life national setting over a decadeMathilde Reich, Derek Dinart, Hélène Bellio, et al.
Cancers|January 21, 2023
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of LeiomyosarcomasElodie Darbo, Gaëlle Pérot, Lucie Darmusey, et al.
The Lancet. Oncology|July 10, 2023
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trialJean-Yves Blay, Sylvie Chevret, Axel Le Cesne, et al.
Cancer|March 12, 2024
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intentJustine Gantzer, Maud Toulmonde, François Severac, et al.
British Journal of Cancer|November 17, 2025
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trialValérie Laurence, Nina Jehanno, Sylvain Dureau, et al.
Pageof 5